English
Syncom Formulations India Ltd Q2 Results
- BSE: 524470
- NSE: SYNCOMF
- ISIN: INE312C01025
- Sector: Biotechnology & Drugs
BSE
11.91
0.15 (1.28%)
0.15 (1.28%)Volume1.07 L
Updated: Thu 22 Jan, 2026 | 10:41:30
NSE
11.930.17 (1.45%)
0.17 (1.45%)Volume6.40 L
Updated: Thu 22 Jan, 2026 | 10:27:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹121.72 Cr.(18.96%)
- Operating Profit₹17.05 Cr.(56.99%)
- Profit After Tax₹16.60 Cr.(49.45%)
- Operating Margin14.01%(31.96%)
Note: Comparison is on YoY basis
Quarterly - Syncom Formulations India Ltd Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 104.67 | 102.39 | 2.22% | 91.45 | 14.45% |
| Depreciation/ Amortization | 1.35 | 1.34 | 0.75% | 1.30 | 3.85% |
| Operating Income | 17.05 | 14.51 | 17.52% | 10.86 | 56.99% |
| Net Income | 16.60 | 15.75 | 5.37% | 11.11 | 49.45% |
| Other Operating Expenses Total | 15.83 | 15.97 | -0.87% | 11.95 | 32.50% |
| Net Income Before Taxes | 22.04 | 20.29 | 8.59% | 14.85 | 48.39% |
| Total Revenue | 121.72 | 116.90 | 4.12% | 102.31 | 18.96% |
| Selling/ General/ Admin Expenses Total | 16.73 | 15.95 | 4.87% | 12.40 | 34.88% |
| Diluted Normalized EPS | 0.18 | 0.21 | -14.11% | 0.16 | 12.50% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.